Reaction
Low Density Lipoprotein Abnormal reporting signals
As of the last recalculation, Low Density Lipoprotein Abnormal appears in 607 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is INCLISIRAN (PRR 149.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Inclisiran | 33 | 149.2 | 149.8 |
| Evolocumab | 198 | 61.7 | 61.7 |
| Alirocumab | 34 | 49.2 | 49.2 |
| Ezetimibe | 79 | 41.4 | 41.4 |
| Pitavastatin Calcium | 6 | 20.3 | 20.3 |
| Icosapent Ethyl | 4 | 16.2 | 16.2 |